Qian Yin

Qian Yin

Stanford University

H-index: 29

North America-United States

About Qian Yin

Qian Yin, With an exceptional h-index of 29 and a recent h-index of 23 (since 2020), a distinguished researcher at Stanford University, specializes in the field of Cancer Immunotherapy, Antiviral vaccine, Nanoparticle therapeutics, Drug delivery, Biomaterials.

His recent articles reflect a diverse array of research interests and contributions to the field:

A structural blueprint for interleukin-21 signal modulation

A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2

Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors

A universal TLR7-nanoparticle adjuvant promotes broad immune responses against heterologous strains of Influenza and SARS-CoV-2

B cell response to vaccination

Nanoparticle-enabled innate immune stimulation activates endogenous tumor-infiltrating T cells with broad antigen specificities

Immune receptor inhibition through enforced phosphatase recruitment

Injectable hydrogels for sustained codelivery of subunit vaccines enhance humoral immunity

Qian Yin Information

University

Position

___

Citations(all)

3658

Citations(since 2020)

2209

Cited By

2200

hIndex(all)

29

hIndex(since 2020)

23

i10Index(all)

34

i10Index(since 2020)

33

Email

University Profile Page

Stanford University

Google Scholar

View Google Scholar Profile

Qian Yin Skills & Research Interests

Cancer Immunotherapy

Antiviral vaccine

Nanoparticle therapeutics

Drug delivery

Biomaterials

Top articles of Qian Yin

Title

Journal

Author(s)

Publication Date

A structural blueprint for interleukin-21 signal modulation

Cell Reports

Gita C Abhiraman

Theodora UJ Bruun

Nathanael A Caveney

Leon L Su

Robert A Saxton

...

2023/6/27

A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2

Nature materials

Qian Yin

Wei Luo

Vamsee Mallajosyula

Yang Bo

Jing Guo

...

2023/3

Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors

Journal for Immunotherapy of Cancer

Ashley R Hoover

Saghar Kaabinejadian

Jason R Krawic

Xiao-Hong Sun

Abdul Rafeh Naqash

...

2022

A universal TLR7-nanoparticle adjuvant promotes broad immune responses against heterologous strains of Influenza and SARS-CoV-2

Qian Yin

Wei Luo

Venkata Vamsee Aditya Mallajosyula

Yang Bo

Jing Guo

...

2021/10/12

B cell response to vaccination

Wei Luo

Qian Yin

2021/10/3

Nanoparticle-enabled innate immune stimulation activates endogenous tumor-infiltrating T cells with broad antigen specificities

Proceedings of the National Academy of Sciences

Qian Yin

Wong Yu

Caitlin L Grzeskowiak

Jing Li

Huang Huang

...

2021/5/25

Immune receptor inhibition through enforced phosphatase recruitment

Nature

Ricardo A Fernandes

Leon Su

Yoko Nishiga

Junming Ren

Aladdin M Bhuiyan

...

2020/10/29

Injectable hydrogels for sustained codelivery of subunit vaccines enhance humoral immunity

ACS central science

Gillie A Roth

Emily C Gale

Marcela Alcántara-Hernández

Wei Luo

Eneko Axpe

...

2020/9/16

Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade

Proceedings of the National Academy of Sciences

Shan Sun

Lingjie Luo

Wenhua Liang

Qian Yin

Jing Guo

...

2020/11/3

See List of Professors in Qian Yin University(Stanford University)